THE NORWEGIAN CANCER SOCIETY
Antimicrobial resistance (AMR) including antibiotic resistance, will set cancer treatment back decades. Incorrect use of antibiotics can lead to the development of resistant or invulnerable bacteria. This means that antibiotics may no longer be effective. We all need to come together to prevent this.
And learn how AMR will affect cancer patients
E-mail us your logo to confirm your support
Your national authorities and general population
Remember to use #AMRcancer
It is estimated that 1 in 5 cancer patients need antibiotics during their cancer treatment. What will the future look like if we no longer have efficient antibiotics?
Norwegian Cancer Society Secretary General Ms. Anne Lise Ryel and Minister of Health Mr. Bent Høie call for urgent action on AMR.
Antimicrobial resistance and its devastating consequences also for cancer treatment have attracted far too little attention from the cancer community. We should indeed care and take responsibility: If we do nothing, we risk having to witness that important progress made in cancer treatment – thanks to the joint efforts from governments, civil society, research institutions and private sector - can be set back decades, while the incidence of cancer cases will continue to rise in the years to come.
Please do not hesitate to contact us if you have any questions.